Innokas Medical entered into cooperation agreement with Swedish company C-RAD AB in 2016. The mutual interest for the companies has been to develop a long-lasting partnership built on trust and with...
Recent Posts
Three manufacturing sites offer flexible contract manufacturing and agile capacity increasing adjusting to customer-specific needs.
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
Headquartered in Helsinki, Finland, MEGIN is the global leader for magnetoencephalography (MEG) technology used for their non-invasive functional brain mapping solution. A long-term collaboration...
The objective of Finnish-based IVD company Aidian is to promote efficient and fluent healthcare by developing and manufacturing reliable, fast and easy to use diagnostic tests for point of care....
High quality combined with cost-effective production can be achieved through optimized manufacturability. This requires a wide range of expertise as well as strategic capabilities.
When creating a new medical device to the market, there’s much more that goes into designing, developing and introducing it to the market. To be able to enter the certain markets, the development and...
Danish company Samplix ApS selected Innokas Medical to co-create the novel Xdrop™ instrument for droplet-based PCR-free enrichment of genomic regions.
